APOB and metabolic syndrome: Indeed, studies show that relying solely on LDL-C can underestimate risk; for example, Paredes et al. found that a substantial proportion of MetS patients with optimal LDL-C had elevated Apo B, non-HDL-C, or oxidized LDL (OxLDL).